{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:47:58Z","timestamp":1778615278951,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Identification and characterisation of monogenic causes of complex neurological phenotypes are important for genetic counselling and prognostication. Bi-allelic pathogenic variants in the gene encoding GLRX5, a protein involved in the early steps of Fe-S cluster biogenesis, are rare and cause two distinct phenotypes: isolated sideroblastic anemia and a neurological phenotype with variant non-ketotic hyperglycinemia. In this study, we analysed the evolution of clinical and MRI findings and long-term outcome of patients with <jats:italic>GLRX5<\/jats:italic> mutations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Four patients from three Australian families of Lebanese descent were identified. All patients presented in childhood and were followed up into adult life through multiple clinical assessments. All were prescribed sodium benzoate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All patients (all females, age range 18\u201356 years) showed a complex neurological phenotype characterised by varying combinations of spastic paraparesis, length-dependent motor\/sensory-motor axonal polyneuropathy, and psychiatric disturbances with variable intellectual disability. All had non-ketotic hyperglycinemia and a homozygous pathogenic c.151_153delAAG (p.K51del) change in <jats:italic>GLRX5.<\/jats:italic> Motor disability gradually progressed reaching moderate disability during adolescence and moderately severe disability during adult life. The major MRI finding was the upper cervical spinal cord signal changes with contrast enhancement noted in all and additional leukoencephalopathy in one. On follow up MRI, the white matter lesions diminished on a subsequent scan and then remained static over time. The spinal cord showed gliotic changes. Two patients have previously demonstrated low pyruvate dehydrogenase complex deficiency but none had plasma lactate elevation, nor biochemical evidence of branch-chain keto-dehydrogenase deficiency. Glycine levels reduced in patients that tolerated sodium benzoate, possibly stabilising clinical manifestations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This report demonstrates that the p.K51del <jats:italic>GLRX5<\/jats:italic> variant causes a distinct and predictable neurological phenotype. The clinical assessments spanning from childhood to adult life enable physicians to infer the natural history of GLRX5 related neurological disorder. There may be widespread metabolic consequences, and optimal management is unknown.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-02073-z","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T14:09:27Z","timestamp":1636121367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["GLRX5-associated [Fe-S] cluster biogenesis disorder: further characterisation of the neurological phenotype and long-term outcome"],"prefix":"10.1186","volume":"16","author":[{"given":"Bindu Parayil","family":"Sankaran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Tchan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beena","family":"Devanapalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusof","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Procopis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0518-5879","authenticated-orcid":false,"given":"Kaustuv","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,3]]},"reference":[{"key":"2073_CR1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1146\/annurev-biochem-013118-111540","volume":"89","author":"R Lill","year":"2020","unstructured":"Lill R, Freibert SA. Mechanisms of mitochondrial iron-sulfur protein biogenesis. Annu Rev Biochem. 2020;89:471\u201399. https:\/\/doi.org\/10.1146\/annurev-biochem-013118-111540.","journal-title":"Annu Rev Biochem"},{"issue":"8","key":"2073_CR2","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.tig.2008.05.008","volume":"24","author":"TA Rouault","year":"2008","unstructured":"Rouault TA, Tong WH. Iron-sulfur cluster biogenesis and human disease. Trends Genet. 2008;24(8):398\u2013407. https:\/\/doi.org\/10.1016\/j.tig.2008.05.008.","journal-title":"Trends Genet"},{"key":"2073_CR3","doi-asserted-by":"publisher","unstructured":"Braymer JJ, Freibert SA, Rakwalska-Bange M, Lill R. Mechanistic concepts of iron-sulfur protein biogenesis in biology. Biochim Biophys Acta Mol Cell Res. 2021;1868(1):118863. https:\/\/doi.org\/10.1016\/j.bbamcr.2020.","DOI":"10.1016\/j.bbamcr.2020."},{"issue":"2","key":"2073_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1242\/dmm.009019","volume":"5","author":"TA Rouault","year":"2012","unstructured":"Rouault TA. Biogenesis of iron-sulfur clusters in mammalian cells: new insights and relevance to human disease. Dis Model Mech. 2012;5(2):155\u201364. https:\/\/doi.org\/10.1242\/dmm.009019.","journal-title":"Dis Model Mech"},{"issue":"4","key":"2073_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00775-018-1550-z","volume":"23","author":"AV Vanlander","year":"2018","unstructured":"Vanlander AV, Van Coster R. Clinical and genetic aspects of defects in the mitochondrial iron-sulfur cluster synthesis pathway. J Biol Inorg Chem. 2018;23(4):495\u2013506. https:\/\/doi.org\/10.1007\/s00775-018-1550-z.","journal-title":"J Biol Inorg Chem"},{"issue":"1","key":"2073_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1039\/c7mt00180k","volume":"10","author":"C Wachnowsky","year":"2018","unstructured":"Wachnowsky C, Fidai I, Cowan JA. Iron-sulfur cluster biosynthesis and trafficking-impact on human disease conditions. Metallomics. 2018;10(1):9\u201329. https:\/\/doi.org\/10.1039\/c7mt00180k.","journal-title":"Metallomics"},{"issue":"4","key":"2073_CR7","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1182\/blood-2007-02-072520","volume":"110","author":"C Camaschella","year":"2007","unstructured":"Camaschella C, Campanella A, De Falco L, Boschetto L, Merlini R, Silvestri L, et al. The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload. Blood. 2007;110(4):1353\u20138.","journal-title":"Blood"},{"issue":"Pt 2","key":"2073_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/brain\/awt328","volume":"137","author":"PR Baker","year":"2014","unstructured":"Baker PR, Friederich MW, Swanson MA, Shaikh T, Bhattacharya K, Scharer GH, et al. Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5. Brain. 2014;137(Pt 2):366\u201379. https:\/\/doi.org\/10.1093\/brain\/awt328.","journal-title":"Brain"},{"issue":"4","key":"2073_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.pediatrneurol.2007.05.016","volume":"37","author":"MA Chiong","year":"2007","unstructured":"Chiong MA, Procopis P, Carpenter K, Wilcken B. Late-onset nonketotic hyperglycinemia with leukodystrophy and an unusual clinical course. Pediatr Neurol. 2007;37(4):283\u20136. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2007.05.016.","journal-title":"Pediatr Neurol"},{"issue":"7","key":"2073_CR10","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1177\/0883073810393965","volume":"26","author":"SH Wei","year":"2011","unstructured":"Wei SH, Weng WC, Lee NC, Hwu WL, Lee WT. Unusual spinal cord lesions in late-onset non-ketotic hyperglycinemia. J Child Neurol. 2011;26(7):900\u20133. https:\/\/doi.org\/10.1177\/0883073810393965.","journal-title":"J Child Neurol"},{"issue":"17","key":"2073_CR11","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1182\/blood-2014-08-598508","volume":"124","author":"G Liu","year":"2014","unstructured":"Liu G, Guo S, Anderson GJ, Camaschella C, Han B, Nie G. Heterozygous missense mutations in the GLRX5 gene cause sideroblastic anemia in a Chinese patient. Blood. 2014;124(17):2750\u20131. https:\/\/doi.org\/10.1182\/blood-2014-08-598508.","journal-title":"Blood"},{"key":"2073_CR12","doi-asserted-by":"publisher","unstructured":"Feng WX, Zhuo XW, Liu ZM, Li JW, Zhang WH, Wu Y, et al. Case report: a variant non-ketotic hyperglycinemia with GLRX5 mutations: manifestation of deficiency of activities of the respiratory chain enzymes. Front Genet. 2021;12:605778. https:\/\/doi.org\/10.3389\/fgene.2021.605778.eCollection2021.","DOI":"10.3389\/fgene.2021.605778.eCollection2021"},{"issue":"10","key":"2073_CR13","first-page":"021","volume":"3","author":"G Sager","year":"2021","unstructured":"Sager G, Turkyilmaz A, Ates EA, Kutlubay B. HACE1, GLRX5, and ELP2 gene variant cause spastic paraplegies. Acta Neurol Belg. 2021;3(10):021\u20131649.","journal-title":"Acta Neurol Belg"},{"issue":"4","key":"2073_CR14","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ajhg.2011.08.011","volume":"89","author":"JM Cameron","year":"2011","unstructured":"Cameron JM, Janer A, Levandovskiy V, Mackay N, Rouault TA, Tong WH, et al. Mutations in iron-sulfur cluster scaffold genes NFU1 and BOLA3 cause a fatal deficiency of multiple respiratory chain and 2-oxoacid dehydrogenase enzymes. Am J Hum Genet. 2011;89(4):486\u201395. https:\/\/doi.org\/10.1016\/j.ajhg.2011.08.011.","journal-title":"Am J Hum Genet"},{"key":"2073_CR15","first-page":"21","volume":"96","author":"WJ Bank","year":"1971","unstructured":"Bank WJ, Morrow G. Familial neuromuscular disease with nonketotic hyperglycinemia. Trans Am Neurol Assoc. 1971;96:21\u20133.","journal-title":"Trans Am Neurol Assoc"},{"issue":"6","key":"2073_CR16","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/s0022-3476(79)80211-5","volume":"94","author":"GS Steiman","year":"1979","unstructured":"Steiman GS, Yudkoff M, Berman PH, Blazer-Yost B, Segal S. Late-onset nonketotic hyperglycinemia and spinocerebellar degeneration. J Pediatr. 1979;94(6):907\u201311. doi:https:\/\/doi.org\/10.1016\/s0022-3476(79)80211-5.","journal-title":"J Pediatr"},{"issue":"8","key":"2073_CR17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2169\/internalmedicine.32.641","volume":"32","author":"Y Tanaka","year":"1993","unstructured":"Tanaka Y, Miyazaki M, Tsuda M, Murai K, Kuzuhara S. Blindness due to non-ketotic hyperglycinemia: report of a 38-year-old, the oldest case to date. Intern Med. 1993;32(8):641\u20132. doi:https:\/\/doi.org\/10.2169\/internalmedicine.32.641.","journal-title":"Intern Med"},{"issue":"5","key":"2073_CR18","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1172\/JCI40372","volume":"120","author":"H Ye","year":"2010","unstructured":"Ye H, Jeong SY, Ghosh MC, Kovtunovych G, Silvestri L, Ortillo D, et al. Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblasts. J Clin Invest. 2010;120(5):1749\u201361.","journal-title":"J Clin Invest"},{"issue":"1","key":"2073_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/jcb.25267","volume":"117","author":"G Liu","year":"2016","unstructured":"Liu G, Wang Y, Anderson GJ, Camaschella C, Chang Y, Nie G. Functional analysis of GLRX5 mutants reveals distinct functionalities of GLRX5 protein. J Cell Biochem. 2016;117(1):207\u201317. https:\/\/doi.org\/10.1002\/jcb.25267.","journal-title":"J Cell Biochem"},{"issue":"3","key":"2073_CR20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1212\/WNL.0000000000001157","volume":"84","author":"NI Wolf","year":"2015","unstructured":"Wolf NI, Toro C, Kister I, Latif KA, Leventer R, Pizzino A, et al. DARS-associated leukoencephalopathy can mimic a steroid-responsive neuroinflammatory disorder. Neurology. 2015;84(3):226\u201330. https:\/\/doi.org\/10.1212\/WNL.0000000000001157.","journal-title":"Neurology"},{"key":"2073_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.msard.2018.01.003","volume":"20","author":"PS Bindu","year":"2018","unstructured":"Bindu PS, Sonam K, Chiplunkar S, Govindaraj P, Nagappa M, Vekhande CC, et al. Mitochondrial leukoencephalopathies: a border zone between acquired and inherited white matter disorders in children? Mult Scler Relat Disord. 2018;20:84\u201392. https:\/\/doi.org\/10.1016\/j.msard.2018.01.003.","journal-title":"Mult Scler Relat Disord"},{"issue":"10","key":"2073_CR22","doi-asserted-by":"publisher","first-page":"e1914274","DOI":"10.1001\/jamanetworkopen.2019.14274","volume":"2","author":"D McCreary","year":"2019","unstructured":"McCreary D, Omoyinmi E, Hong Y, Mulhern C, Papadopoulou C, Casimir M, et al. Development and validation of a targeted next-generation sequencing gene panel for children with neuroinflammation. JAMA Netw Open. 2019;2(10):e1914274. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.14274.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"2073_CR23","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1093\/brain\/awy172","volume":"141","author":"J Gurgel-Giannetti","year":"2018","unstructured":"Gurgel-Giannetti J, Lynch DS, Paiva ARB, Lucato LT, Yamamoto G, Thomsen C, et al. A novel complex neurological phenotype due to a homozygous mutation in FDX2. Brain. 2018;141(8):2289\u201398. doi:https:\/\/doi.org\/10.1093\/brain\/awy172.","journal-title":"Brain"},{"issue":"6","key":"2073_CR24","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/ana.21692","volume":"65","author":"AL Oaklander","year":"2009","unstructured":"Oaklander AL, Fields HL. Is reflex sympathetic dystrophy\/complex regional pain syndrome type I a small-fiber neuropathy? Ann Neurol. 2009;65(6):629\u201338. doi:https:\/\/doi.org\/10.1002\/ana.21692.","journal-title":"Ann Neurol"},{"issue":"1","key":"2073_CR25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s13311-015-0395-1","volume":"13","author":"AL Oaklander","year":"2016","unstructured":"Oaklander AL. Immunotherapy prospects for painful small-fiber sensory neuropathies and ganglionopathies. Neurotherapeutics. 2016;13(1):108\u201317. https:\/\/doi.org\/10.1007\/s13311-015-0395-1.","journal-title":"Neurotherapeutics"},{"key":"2073_CR26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jpeds.2015.12.027","volume":"170","author":"KJ Bjoraker","year":"2016","unstructured":"Bjoraker KJ, Swanson MA, Coughlin CR, Christodoulou J, Tan ES, Fergeson M, et al. Neurodevelopmental outcome and treatment efficacy of benzoate and dextromethorphan in siblings with attenuated nonketotic gyperglycinemia. J Pediatr. 2016;170:234\u20139.","journal-title":"J Pediatr"},{"key":"2073_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13023-015-0237-6","volume":"10","author":"D Tonduti","year":"2015","unstructured":"Tonduti D, Dorboz I, Imbard A, Slama A, Boutron A, Pichard S, et al. New spastic paraplegia phenotype associated to mutation of NFU1. Orphanet J Rare Dis. 2015;10:13. https:\/\/doi.org\/10.1186\/s13023-015-0237-6.","journal-title":"Orphanet J Rare Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02073-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-02073-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02073-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T14:12:06Z","timestamp":1636121526000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-02073-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,3]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2073"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-02073-z","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,3]]},"assertion":[{"value":"19 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was provided by SCHN (2018\/ETH00609)\u2014all patients provided written consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients provided written consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"465"}}